Africa institutional business unpredictability
Africa institutional revenue fell 36% YoY due to procurement schedule shifts; management noted this business remains unpredictable.
AJANTPHARM / Q1-FY25 / risks
Keep the risk register visible.
Ajanta Pharma · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Freight cost headwind of INR 30 crore
Management expects an adverse impact of INR 30 crore in freight costs for FY25 compared to FY24, assuming current rates persist.
US price erosion in high single digits
US generic price erosion remains stable but at high single digits, which could pressure margins if competition intensifies.
Employee cost one-time charge normalization
Q1 employee costs included a one-time INR 30 crore gratuity policy change; while normalized in subsequent quarters, it highlights potential for future policy-driven cost increases.